the immunogenicity and safety of a standard dose of 10 micrograms of a yeast derived recombinant dna hepatitis b vaccine ( b-hepavac ii ) was compared with that of a reduced dose of 5 micrograms in 84 healthy adult volunteers with no previous exposure to hepatitis b .
C0062527
recombinant
C0019163
hepatitis b